Cybin Inc. Common Stock
HELP
Rank in Stocks
#11661
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Share Price
$10.30
Last synced: 2026-08-11
Market Cap
$638.32M
Change (1 day)
2.88%
Change (1 year)
9,119.52%
Country
CA
Trade Cybin Inc. Common Stock (HELP)
Category
Healthcare
Stock price history for Cybin Inc. Common Stock (HELP)
Highest end of day price: $0.12 on 2023-10-01
Lowest end of day price: $0.40 on 2021-06-01
Lowest end of day price: $0.40 on 2021-06-01
Stock price history of Cybin Inc. Common Stock from 2021 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2023 | 81.70% |
| 2022 | -76.32% |
| 2021 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
